Ali Fattaey
- Molecular Biology top 1%
- Oncology top 0.5%
- Genetics top 0.5%
- Cell Biology top 2%
- Biotechnology top 0.5%
- Co-authors
- Kristian HelinE HarlowMichelle D. GarrettNicholas J. DysonMarc VidalJacqueline A. LeesLauren StevensonCharanjit Sandhu
- Topics
- Cancer-related Molecular Pathways (17 papers)Virus-based gene therapy research (14 papers)Ubiquitin and proteasome pathways (4 papers)
- Cited by
- OncologyGeneticsBiotechnology
- Partner nations
- United StatesDenmarkIsrael
In The Last Decade
Ali Fattaey
33 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Molecular Biology 4.6k
- Oncology 4.0k
- Genetics 2.3k
- Cell Biology 689
- Biotechnology 622
Countries citing papers authored by Ali Fattaey
This map shows the geographic impact of Ali Fattaey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Fattaey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Fattaey more than expected).
Fields of papers citing papers by Ali Fattaey
This network shows the impact of papers produced by Ali Fattaey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Fattaey. The network helps show where Ali Fattaey may publish in the future.
Co-authorship network of co-authors of Ali Fattaey
This figure shows the co-authorship network connecting the top 25 collaborators of Ali Fattaey. A scholar is included among the top collaborators of Ali Fattaey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Fattaey. Ali Fattaey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 0 | |
| 3 | 109 | |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 150 | |
| 7 | 90 | |
| 8 | 2 | |
| 9 | 130 | |
| 10 | 120 | |
| 11 | 232 | |
| 12 | 61 | |
| 13 | 229 | |
| 14 | 46 | |
| 15 | 10 | |
| 16 | 442 | |
| 17 | 140 | |
| 18 | 16 | |
| 19 | A cDNA encoding a pRB-binding protein with properties of the transcription factor E2Fbreakdown → | 577 |
| 20 | 18 |
About Ali Fattaey
Ali Fattaey is a scholar working on Oncology, Genetics and Biotechnology, having authored 34 papers that have together received 6.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (17 papers), Virus-based gene therapy research (14 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Oncology (4.0k citations), Genetics (2.3k citations) and Biotechnology (622 citations). Ali Fattaey has collaborated with scholars based in United States, Denmark and Israel. Frequent co-authors include Kristian Helin, E Harlow, Michelle D. Garrett, Nicholas J. Dyson, Marc Vidal, Jacqueline A. Lees, Lauren Stevenson, Charanjit Sandhu, Joshua LaBaer and Joyce M. Slingerland. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.